Katyayini Aribindi

2PUBLICATIONS
3CO-AUTHORS
Pharmaceutical delivery technologiesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 28, 2024
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).

Katyayini Aribindi, Gabrielle Y Liu, Timothy E Albertson

|Apr 06, 2019
Acute myocardial infarction and renal dysfunction due to chronic extreme anemia (hemoglobin 2.5 g/dL) in immune thrombocytopenia.

Mark Muenchrath, Katyayini Aribindi, Mark Farnie

Pageof 1